When did Crinetics Pharmaceuticals report Q4 2024 earnings?

Crinetics Pharmaceuticals (CRNX) reported Q4 2024 earnings on February 27, 2025 after market close.

What were Crinetics Pharmaceuticals's Q4 2024 revenue and EPS?

Crinetics Pharmaceuticals reported revenue of - and eps of $-0.88 for Q4 2024.

Did Crinetics Pharmaceuticals beat estimates in Q4 2024?

EPS beat the consensus estimate of $-0.92 by $0.04.

Where can I find Crinetics Pharmaceuticals's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-029050) directly on SEC EDGAR. The filing index links above go to sec.gov.

Crinetics Pharmaceuticals CRNX Q4 2024 Annual earnings

Reported February 27, 2025 · After market close

Revenue-

EPS-$0.88Beat by $0.04

EPS estimate-$0.92

Next report

Aug 4, 2026 (In 5 days)

Revenue estimate$14.8M

EPS estimate-$1.23

Financials

Q4 2024

Income statement

See full

Revenue-—

Gross profit$259.8K-74.1%

Operating income-$94.7M-51.2%

Net income-$80.6M-34.1%

EPS (diluted)-$0.87+1.1%

Balance sheet

See full

Cash & equivalents$265.8M+373%

Total debt$51.7M0.0%

Total equity$1.3B+146%

Total assets$1.4B+126%

Cash flow

See full

Operating cash flow-$66.9M-63.9%

CapEx$1.0M+10.1%

Free cash flow-$67.9M-62.7%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$4.74B+99.5%

Enterprise value$4.53B+90.9%

P/S4,563.7×+3,971×

Profitability

See full

Gross margin100%0.0pp

Operating margin-32,613.5%-41,021pp

Net margin-28,720.7%-37,237pp

FCF margin-22,525.3%-29,528pp

Returns & leverage

See full

Return on equity-32%-8.5pp

Debt / equity0×-0.1×

Current ratio23×+10.0×

Segments

By product

See full

Collaboration and license revenue$259.8K-74.1%

Versus estimates

Revenue

Q1 2026$10.7MBeat by $2.2M Q4 2025$6.2MBeat by $1.7M Q3 2025$143.0KMiss by $4.2M Q2 2025$1.0MBeat by $637.0K Q1 2025$361.0KBeat by $13.1K

Diluted EPS

Q1 2026-$1.23Miss by $0.01 Q4 2025-$1.29Beat by $0.08 Q3 2025-$1.38Miss by $0.11 Q2 2025-$1.23Miss by $0.10 Q1 2025-$1.04Miss by $0.05

Q4 2024-$0.88Beat by $0.04

Ask the moment Crinetics Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Crinetics Pharmaceuticals report Q4 2024 earnings?: Crinetics Pharmaceuticals (CRNX) reported Q4 2024 earnings on February 27, 2025 after market close.
What were Crinetics Pharmaceuticals's Q4 2024 revenue and EPS?: Crinetics Pharmaceuticals reported revenue of - and eps of $-0.88 for Q4 2024.
Did Crinetics Pharmaceuticals beat estimates in Q4 2024?: EPS beat the consensus estimate of $-0.92 by $0.04.
Where can I find Crinetics Pharmaceuticals's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-029050) directly on SEC EDGAR. The filing index links above go to sec.gov.